Simulations Plus, Inc. (NASDAQ: SLP) is a publicly listed provider of drug-discovery and drug-development modeling and simulation software, including ADMET, PBPK and QSP tools, together with related scientific consulting services for pharmaceutical and biotechnology customers.
Focus Areas
Notable Investments
